APA (7th ed.) Citation

Sun, L., Xie, C., Wang, G., Wu, Y., Wu, Q., Wang, X., . . . Jiang, C. (2018). Gut microbiota and intestinal FXR mediate the clinical benefits of metformin. Nature medicine, 24(12), 1919-1929. https://doi.org/10.1038/s41591-018-0222-4

Chicago Style (17th ed.) Citation

Sun, Lulu, et al. "Gut Microbiota and Intestinal FXR Mediate the Clinical Benefits of Metformin." Nature Medicine 24, no. 12 (2018): 1919-1929. https://doi.org/10.1038/s41591-018-0222-4.

MLA (9th ed.) Citation

Sun, Lulu, et al. "Gut Microbiota and Intestinal FXR Mediate the Clinical Benefits of Metformin." Nature Medicine, vol. 24, no. 12, 2018, pp. 1919-1929, https://doi.org/10.1038/s41591-018-0222-4.